As shown in Figure 3A (exp. 1; black bars), two kinds of sera (IgG-major and IgM-major) of the convalescents recovering from severe COVID-19 inhibited around 50% of the pseudo-virus infection at dilutions of up to 960-fold. This evidence concerns the gene CD40LG and viral infectious disease.